» Articles » PMID: 18709448

Flocculated Amorphous Nanoparticles for Highly Supersaturated Solutions

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 2008 Aug 19
PMID 18709448
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To recover polymer-stabilized amorphous nanoparticles from aqueous dispersions efficiently by salt flocculation and to show that the particles redisperse and dissolve rapidly to produce highly supersaturated solutions.

Methods: Nanoparticle dispersions of itraconazole stabilized by nonionic polymers were formed by antisolvent precipitation and immediately flocculated with sodium sulfate, filtered and dried. The size after redispersion in water, crystallinity, and morphology were compared with those for particles produced by spray drying and rapid freezing.

Results: Particle drug loading increased to approximately 90% after salt flocculation and removal of excess polymer with the filtrate. The formation of the flocs at constant particle volume fraction led to low fractal dimensions (open flocs), which facilitated redispersion in water to the original primary particle size of approximately 300 nm. Amorphous particles, which were preserved throughout the flocculation-filtration-drying process, dissolved to supersaturation levels of up to 14 in pH 6.8 media. In contrast, both spray dried and rapidly frozen nanoparticle dispersions crystallized and did not produce submicron particle dispersions upon addition to water, nor high supersaturation values.

Conclusions: Salt flocculation produces large yields of high surface area amorphous nanoparticle powders that de-aggregate and dissolve rapidly upon redispersion in pH 6.8 media, for supersaturation levels up to 14.

Citing Articles

Fragment-based drug nanoaggregation reveals drivers of self-assembly.

Chen C, Wu Y, Wang S, Berisha N, Manzari M, Vogt K Nat Commun. 2023; 14(1):8340.

PMID: 38097573 PMC: 10721832. DOI: 10.1038/s41467-023-43560-0.


Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale.

Feng J, Markwalter C, Tian C, Armstrong M, Prudhomme R J Transl Med. 2019; 17(1):200.

PMID: 31200738 PMC: 6570894. DOI: 10.1186/s12967-019-1945-9.


Application of flash nanoprecipitation to fabricate poorly water-soluble drug nanoparticles.

Tao J, Chow S, Zheng Y Acta Pharm Sin B. 2019; 9(1):4-18.

PMID: 30766774 PMC: 6361851. DOI: 10.1016/j.apsb.2018.11.001.


Rapid Recovery of Clofazimine-Loaded Nanoparticles with Long-Term Storage Stability as Anti- Therapy.

Feng J, Zhang Y, McManus S, Ristroph K, Lu H, Gong K ACS Appl Nano Mater. 2018; 1(5):2184-2194.

PMID: 29911689 PMC: 5999231. DOI: 10.1021/acsanm.8b00234.


Design and Solidification of Fast-Releasing Clofazimine Nanoparticles for Treatment of Cryptosporidiosis.

Zhang Y, Feng J, McManus S, Lu H, Ristroph K, Cho E Mol Pharm. 2017; 14(10):3480-3488.

PMID: 28929769 PMC: 5627342. DOI: 10.1021/acs.molpharmaceut.7b00521.


References
1.
Jacobs C, Kayser O, Muller R . Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. Int J Pharm. 2000; 196(2):161-4. DOI: 10.1016/s0378-5173(99)00412-3. View

2.
Merisko-Liversidge E, Liversidge G, Cooper E . Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci. 2003; 18(2):113-20. DOI: 10.1016/s0928-0987(02)00251-8. View

3.
Hasegawa A, Kawamura R, Nakagawa H, Sugimoto I . Physical properties of solid dispersions of poorly water-soluble drugs with enteric coating agents. Chem Pharm Bull (Tokyo). 1985; 33(8):3429-35. DOI: 10.1248/cpb.33.3429. View

4.
Six K, Berghmans H, Leuner C, Dressman J, Van Werde K, Mullens J . Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion, Part II. Pharm Res. 2003; 20(7):1047-54. DOI: 10.1023/a:1024414423779. View

5.
Holmes , Johnston , Doty , Korgel . Control of thickness and orientation of solution-grown silicon nanowires. Science. 2000; 287(5457):1471-3. DOI: 10.1126/science.287.5457.1471. View